Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1/2 1Phase 1 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Non-Small-Cell Lung 229Squamous Cell Carcinoma of Head and Neck 138Head and Neck Neoplasms 130Lung Neoplasms 117Esophageal Neoplasms 88Stomach Neoplasms 84Uterine Cervical Neoplasms 66Esophageal Squamous Cell Carcinoma 65Urinary Bladder Neoplasms 59Breast Neoplasms 55Nasopharyngeal Carcinoma 51Small Cell Lung Carcinoma 46Carcinoma, Squamous Cell 39Neoplasm Metastasis 38Pancreatic Neoplasms 36Neoplasms 35Biliary Tract Neoplasms 34Oropharyngeal Neoplasms 32Cholangiocarcinoma 32Ovarian Neoplasms 30Mesothelioma, Malignant 28Adenocarcinoma Of Esophagus 28Lymphoma 25Carcinoma 24Adenocarcinoma of Lung 24Central Nervous System Neoplasms 22Laryngeal Neoplasms 20Carcinoma, Ovarian Epithelial 20Recurrence 19Lymphoma, Large B-Cell, Diffuse 19

Interventions

Paclitaxel 4Oxaliplatin 4Cisplatin 4Radiotherapy 3Ocoxin 3Folfox protocol 3pembrolizumab 2camrelizumab 2apatinib 2anlotinib 2Sunitinib 2Sorafenib 2Imatinib Mesylate 2Gemcitabine 2Fluorouracil 2Drug Therapy 2Capecitabine 2Bevacizumab 2tislelizumab 1sintilimab 1regorafenib 1pyrotinib 1pemigatinib 1genexol-PM 1durvalumab 1donafenib 1copanlisib 1atezolizumab 1alectinib 1Tretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Digestive System Neoplasms × Cisplatin × Clear all
NCT05262335 2023-11-28

ALTER-G-001

Ruijin Hospital

Phase 2 Unknown
116 enrolled
Gastrointestinal

Digestive System Neoplasms

NCT05281003 2023-07-13

HYPERION

Fudan University

Phase 2 Recruiting
128 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Hypoxia, Digestive System Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Neoplasms

NCT02631590 2021-08-04

Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
24 enrolled 11 charts
Gastrointestinal

Digestive System Neoplasms, Gallbladder Neoplasms, Neoplasm Metastasis, Cholangiocarcinoma

NCT02644863 2016-05-24

Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer

Shenzhen Hornetcorn Bio-technology Company, LTD

Phase 2 Unknown
60 enrolled
Gastrointestinal

Digestive System Neoplasms, Esophageal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡